Head to Head Comparison: Mural Oncology (NASDAQ:MURA) & FutureWorld (OTCMKTS:FWDG)

Mural Oncology (NASDAQ:MURAGet Free Report) and FutureWorld (OTCMKTS:FWDGGet Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership.

Institutional & Insider Ownership

80.2% of Mural Oncology shares are held by institutional investors. 0.1% of Mural Oncology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Mural Oncology and FutureWorld”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mural Oncology N/A N/A -$207.45 million ($9.14) -0.49
FutureWorld N/A N/A N/A N/A N/A

Profitability

This table compares Mural Oncology and FutureWorld’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mural Oncology N/A -70.10% -61.30%
FutureWorld N/A N/A N/A

Analyst Recommendations

This is a summary of current ratings and target prices for Mural Oncology and FutureWorld, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mural Oncology 0 0 3 1 3.25
FutureWorld 0 0 0 0 0.00

Mural Oncology currently has a consensus target price of $16.00, suggesting a potential upside of 257.94%. Given Mural Oncology’s stronger consensus rating and higher possible upside, equities analysts plainly believe Mural Oncology is more favorable than FutureWorld.

Summary

Mural Oncology beats FutureWorld on 6 of the 8 factors compared between the two stocks.

About Mural Oncology

(Get Free Report)

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

About FutureWorld

(Get Free Report)

FutureWorld Corp., together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of hemp/cannabis products, services, and technologies worldwide. The company provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation, and consultation for the industrial hemp and legal medicinal marijuana. It offers personal and professional tetrahydrocannabinoil and Cannabidiol test kits; pharmaceutical grade CBD oil solutions; URVape vaporizer pens, which are oil vaporizers for the e-cigarette, cannabis, and herbal vaping industry; CaNNaLyTiX, a dashboard controller system that allows various computer systems to be integrated throughout a cultivator's infrastructures; CaNNaTRAK, the barcode and RFID tracking systems for keeping seed to sale tracking of hemp/cannabis; and SPIDer (secure perimeter intrusion detection network), a system to meet the needs of theft and malicious attacks. The company also provides SmartSense, which offers wireless security and smart sensor mesh network for precision agriculture, irrigation systems, and greenhouses for the hemp industry; SmartNergy that offers tools to analyze various aspects of a cultivator's energy usage; and CaNNaBoX machine, which operates with the swipe of a card to verify identity, age, and prescription information of a medical marijuana patient before releasing measured packages of marijuana. Its target customers include consumers via Internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, affiliate sales, and master distributors. The company was formerly known as FutureWorld Energy, Inc. and changed its name to FutureWorld Corp. in June 2014. FutureWorld Corp. was founded in 2002 and is based in Saint Petersburg, Florida.

Receive News & Ratings for Mural Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mural Oncology and related companies with MarketBeat.com's FREE daily email newsletter.